Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Area Under Curve. Found 12 abstracts

Xia J, Flynn W, Levy RM. Improving Prediction Accuracy of Binding Free Energies and Poses of HIV Integrase Complexes Using the Binding Energy Distribution Analysis Method with Flattening Potentials. Journal of chemical information and modeling. 2018 Jul 23;58(7):1356-71.   PMCID: PMC6287956
Pollack A, Kwon D, Walker G, Khor LY, Horwitz EM, Buyyounouski MK, Stoyanova R. Prospective Validation of Diagnostic Tumor Biomarkers in Men Treated With Radiotherapy for Prostate Cancer. Journal of the National Cancer Institute. 2017 Feb;109(2):1-8.   PMCID: PMC6075027
Infante JR, Dees EC, Olszanski AJ, Dhuria SV, Sen S, Cameron S, Cohen RB. Phase I Dose-Escalation Study of LCL161, an Oral Inhibitor of Apoptosis Proteins Inhibitor, in Patients With Advanced Solid Tumors. J Clin Oncol. 2014 Oct;32(28):3103-10.
Mateo J, Berlin J, de Bono JS, Cohen RB, Keedy V, Mugundu G, Zhang L, Abbattista A, Davis C, Gallo Stampino C, Borghaei H. A first-in-human study of the anti-alpha5beta1 integrin monoclonal antibody PF-04605412 administered intravenously to patients with advanced solid tumors. Cancer Chemother Pharmacol. 2014 Nov;74(5):1039-46.   PMCID: Pmc4209234
Cohen RB, Aamdal S, Nyakas M, Cavallin M, Green D, Learoyd M, Smith I, Kurzrock R. A phase I dose-finding, safety and tolerability study of AZD8330 in patients with advanced malignancies. Eur J Cancer. 2013 May;49(7):1521-9.   PMCID: *
Rinella ES, Shao Y, Yackowski L, Pramanik S, Oratz R, Schnabel F, Guha S, LeDuc C, Campbell CL, Klugman SD, Terry MB, Senie RT, Andrulis IL, Daly M, John EM, Roses D, Chung WK, Ostrer H. Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation. Hum Genet. 2013 May;132(5):523-36.
Cohen SJ, Leichman CG, Yeslow G, Beard M, Proefrock A, Roedig B, Damle B, Letrent SP, DeCillis AP, Meropol NJ. Phase I and pharmacokinetic study of once daily oral administration of s-1 in patients with advanced cancer. Clin Cancer Res. 2002 Jul;8(7):2116-22.
Crul M, de Klerk GJ, Swart M, Weiner L, Palmer PA, Bol CJ, Beijnen JH, Schellens JH. Evaluation of the bioequivalence of tablets and capsules containing the novel anticancer agent R115777 (Zarnestra) in patients with advanced solid tumors. Eur J Drug Metab Pharmacokinet. 2002 Jan;27(1):61-5.
Shen M, Schilder RJ, Obasaju C, Gallo JM. Population pharmacokinetic and limited sampling models for carboplatin administered in high-dose combination regimens with peripheral blood stem cell support. Cancer Chemother Pharmacol. 2002 Sep;50(3):243-50.
Langer CJ, McAleer CA, Bonjo CA, Litwin S, Millenson M, Kosierowski R, Blankstein K, Alexander R, Ozols RF. Paclitaxel by 1-h infusion in combination with carboplatin in advanced non-small cell lung carcinoma (NSCLC). Eur J Cancer. 2000 Jan;36(2):183-93.
Qian M, Chen SH, von Hofe E, Gallo JM. Pharmacokinetics and tissue distribution of a DNA-methyltransferase antisense (MT-AS) oligonucleotide and its catabolites in tumor-bearing nude mice. The Journal of pharmacology and experimental therapeutics. 1997 Aug;282(2):663-70.
O'Dwyer PJ, Laub PB, DeMaria D, Qian M, Reilly D, Giantonio B, Johnston AL, Wu EY, Bauman L, Clendeninn NJ, Gallo JM. Phase I trial of the thymidylate synthase inhibitor AG331 as a 5-day continuous infusion. Clin Cancer Res. 1996 Oct;2(10):1685-92.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Area Under Curve

Area Under Curve Female drug therapy Adult pharmacokinetics Aged Male Human therapeutic use Neoplasms Drug Administration Schedule metabolism Middle Aged adverse effects chemically induced Middle Age administration & dosage pathology Drug Dose-Response Relationship 80 and over Aged Antineoplastic Agents ROC Curve Nausea Fatigue genetics Treatment Outcome Metabolic Clearance Rate Non-US Gov't Support US Gov't Support-PHS Vomiting blood antagonists & inhibitors Antineoplastic Combined Chemotherapy Protocols Diarrhea Cohort Studies Oral Administration High Pressure Liquid Chromatography Combined Modality Therapy Tablets Intravenous Infusions Mutation Biological Availability Carboplatin Lung Neoplasms chemistry Dermatitis Tumor Suppressor Protein p53 Hormonal Antineoplastic Agents Animal Jews Thermodynamics Comparative Study Capillary Electrophoresis Ion Exchange Chromatography Haplotypes Flushing effects Antineoplastic Antimetabolites Proto-Oncogene Proteins c-mdm2 Adolescent Ligands Bilirubin Case-Control Studies Drug Combinations Thiazoles Ovarian Neoplasms Protein Kinase Inhibitors Neoplasm Transplantation immunology Tegafur BRCA1 Protein Androgen Antagonists Inhibitor of Apoptosis Proteins Syndrome Ductal Carcinoma-Breast Thymidylate Synthase radiotherapy Molecular Dynamics Simulation bcl-2-Associated X Protein Cytokines Treatment Failure Genome-Wide Association Study Cyclooxygenase 2 Ki-67 Antigen BRCA2 Protein Protein Binding Chemical Databases Maximum Tolerated Dose Acne Vulgaris Fever Quinolones Cyclin-Dependent Kinase Inhibitor p16 Alanine Transaminase Population Genetics Hypotension Integrin alpha5beta1 Monoclonal Antibodies-Humanized Genotype Capsules Breast Neoplasms Pharmaceutical Solutions Theoretical Models secretion Forecasting Prostate-Specific Antigen Muramidase Aspartate Aminotransferases Dihydropyridines Dose Fractionation Pyridines Survival Rate HIV Integrase Binding Sites Non-Small-Cell Lung Carcinoma Mice Tissue Distribution Xylenes Risk Assessment use Half-Life Molecular Conformation Enzyme Inhibitors Hematopoietic Stem Cell Transplantation Gastrointestinal Diseases Tumor Biomarkers Indoles MAP Kinase Kinase 2 Prostatic Neoplasms Proto-Oncogene Proteins c-bcl-2 Young Adult Nude Mice ethnology DNA Modification Methylases Follow-Up Studies Paclitaxel Prospective Studies etiology Cross-Over Studies MAP Kinase Kinase 1 Computer Simulation Oxonic Acid Antisense Oligonucleotides drug effects Single Nucleotide Polymorphism analysis therapeutic adverse
Last updated on Wednesday, March 04, 2020